NCT00997152View on ClinicalTrials.gov

Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients

PHASE2TerminatedINTERVENTIONAL

Enrollment

152

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

April 30, 2010

Conditions

Type II Diabetes Mellitus

Interventions

DRUG

JTT-654

Tablets

DRUG

JTT-654 Placebo

Tablets

Trial Locations (42)

Unknown

Birmingham

Chandler

Phoenix

Tempe

Chino

Greenbrae

Huntington Park

Los Angeles

Paramount

Sacramento

Walnut Creek

West Covina

DeLand

Hialeah

Hollywood

Jacksonville

Miami

Port Orange

Marietta

Addison

Chicago

Indianapolis

Oxon Hill

New Bedford

Great Falls

Charlotte

Morehead City

Cincinnati

Marion

Oklahoma City

Lansdale

Bristol

Carrollton

Corpus Christi

Dallas

Houston

Katy

San Antonio

Sugar Land

Norfolk

Richmond

Virginia Beach

Sponsors

Lead Sponsor

Akros Pharma Inc.

All Listed Sponsors

lead

Akros Pharma Inc.

INDUSTRY

NCT00997152 - Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients | Biotech Hunter | Biotech Hunter